Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Medtronic
Mallinckrodt
Moodys
Baxter

Last Updated: May 26, 2022

Mylan Pharms Inc Company Profile


✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for MYLAN PHARMS INC, and what generic and branded alternatives to MYLAN PHARMS INC drugs are available?

MYLAN PHARMS INC has one hundred and eight approved drugs.



Summary for Mylan Pharms Inc
US Patents:0
Tradenames:94
Ingredients:93
NDAs:108

Drugs and US Patents for Mylan Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc VALACYCLOVIR HYDROCHLORIDE valacyclovir hydrochloride TABLET;ORAL 078518-001 May 24, 2010 AB RX No No See Plans and Pricing See Plans and Pricing
Mylan Pharms Inc ESCITALOPRAM OXALATE escitalopram oxalate CAPSULE;ORAL 077660-002 Jul 31, 2007 DISCN No No See Plans and Pricing See Plans and Pricing
Mylan Pharms Inc PAROXETINE HYDROCHLORIDE paroxetine hydrochloride TABLET;ORAL 075716-001 Mar 8, 2004 DISCN No No See Plans and Pricing See Plans and Pricing
Mylan Pharms Inc CLINDAMYCIN HYDROCHLORIDE clindamycin hydrochloride CAPSULE;ORAL 091225-002 May 31, 2011 DISCN No No See Plans and Pricing See Plans and Pricing
Mylan Pharms Inc ESCITALOPRAM OXALATE escitalopram oxalate CAPSULE;ORAL 077660-001 Jul 31, 2007 DISCN No No See Plans and Pricing See Plans and Pricing
Mylan Pharms Inc DIDANOSINE didanosine CAPSULE, DELAYED REL PELLETS;ORAL 090788-004 Apr 8, 2010 DISCN No No See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Express Scripts
Moodys
AstraZeneca
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.